170 related articles for article (PubMed ID: 21771578)
21. Development of fluorescence polarization-based competition assay for nicotinamide N-methyltransferase.
Iyamu ID; Huang R
Anal Biochem; 2020 Sep; 604():113833. PubMed ID: 32622979
[TBL] [Abstract][Full Text] [Related]
22. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
23. A 96-well microtiter plate assay for high-throughput screening of Mycobacterium tuberculosis dTDP-d-glucose 4,6-dehydratase inhibitors.
Shi X; Sha S; Liu L; Li X; Ma Y
Anal Biochem; 2016 Apr; 498():53-8. PubMed ID: 26778528
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
[TBL] [Abstract][Full Text] [Related]
25. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
Kurth DG; Gago GM; de la Iglesia A; Bazet Lyonnet B; Lin TW; Morbidoni HR; Tsai SC; Gramajo H
Microbiology (Reading); 2009 Aug; 155(Pt 8):2664-2675. PubMed ID: 19423629
[TBL] [Abstract][Full Text] [Related]
26. Development of a fluorescence anisotropy-based assay for Dop, the first enzyme in the pupylation pathway.
Hecht N; Gur E
Anal Biochem; 2015 Sep; 485():97-101. PubMed ID: 26095396
[TBL] [Abstract][Full Text] [Related]
27. Expanding the chemical diversity of natural esters by engineering a polyketide-derived pathway into Escherichia coli.
Menendez-Bravo S; Comba S; Sabatini M; Arabolaza A; Gramajo H
Metab Eng; 2014 Jul; 24():97-106. PubMed ID: 24831705
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the development of potential inhibitors targeting FadD23 from Mycobacterium tuberculosis.
Yan M; Ma M; Chen R; Cao Y; Zhang W; Liu X
Acta Crystallogr F Struct Biol Commun; 2023 Aug; 79(Pt 8):208-216. PubMed ID: 37522751
[TBL] [Abstract][Full Text] [Related]
29. A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interaction.
Kimple AJ; Yasgar A; Hughes M; Jadhav A; Willard FS; Muller RE; Austin CP; Inglese J; Ibeanu GC; Siderovski DP; Simeonov A
Comb Chem High Throughput Screen; 2008 Jun; 11(5):396-409. PubMed ID: 18537560
[TBL] [Abstract][Full Text] [Related]
30. Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis.
Rousseau C; Sirakova TD; Dubey VS; Bordat Y; Kolattukudy PE; Gicquel B; Jackson M
Microbiology (Reading); 2003 Jul; 149(Pt 7):1837-1847. PubMed ID: 12855735
[TBL] [Abstract][Full Text] [Related]
31. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.
Gagne A; Banks P; Hurt SD
J Recept Signal Transduct Res; 2002; 22(1-4):333-43. PubMed ID: 12503625
[TBL] [Abstract][Full Text] [Related]
32. Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis.
Lin TW; Melgar MM; Kurth D; Swamidass SJ; Purdon J; Tseng T; Gago G; Baldi P; Gramajo H; Tsai SC
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3072-7. PubMed ID: 16492739
[TBL] [Abstract][Full Text] [Related]
33. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
Cho EJ; Xia S; Ma LC; Robertus J; Krug RM; Anslyn EV; Montelione GT; Ellington AD
J Biomol Screen; 2012 Apr; 17(4):448-59. PubMed ID: 22223052
[TBL] [Abstract][Full Text] [Related]
34. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
Reindl W; Gräber M; Strebhardt K; Berg T
Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
[TBL] [Abstract][Full Text] [Related]
35. Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria.
Azad AK; Sirakova TD; Fernandes ND; Kolattukudy PE
J Biol Chem; 1997 Jul; 272(27):16741-5. PubMed ID: 9201977
[TBL] [Abstract][Full Text] [Related]
36. A fluorescence polarization-based assay for the identification and evaluation of calmodulin antagonists.
Arai T; Yatabe M; Furui M; Akatsuka H; Uehata M; Kamiyama T
Anal Biochem; 2010 Oct; 405(2):147-52. PubMed ID: 20599654
[TBL] [Abstract][Full Text] [Related]
37. 4'-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo.
Leblanc C; Prudhomme T; Tabouret G; Ray A; Burbaud S; Cabantous S; Mourey L; Guilhot C; Chalut C
PLoS Pathog; 2012 Dec; 8(12):e1003097. PubMed ID: 23308068
[TBL] [Abstract][Full Text] [Related]
38. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
[TBL] [Abstract][Full Text] [Related]
39. A fluorescence polarization binding assay to identify inhibitors of flavin-dependent monooxygenases.
Qi J; Kizjakina K; Robinson R; Tolani K; Sobrado P
Anal Biochem; 2012 Jun; 425(1):80-7. PubMed ID: 22410281
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.
Khare G; Gupta V; Gupta RK; Gupta R; Bhat R; Tyagi AK
PLoS One; 2009 Dec; 4(12):e8387. PubMed ID: 20027301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
